Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Boris Gershman MD

Boris Gershman MD

Assistant Professor of Surgery, Harvard Medical School, Boston, MA Division of Urologic Surgery, Beth Israel Deaconess Medical Center, Boston, Massachusetts

Dr. Gershman is a urologic oncologist in the Division of Urologic Surgery at Beth Israel Deaconess Medical Center and an Assistant Professor of Surgery at Harvard Medical School. His clinical practice focuses on the management of urologic malignancies, including bladder, prostate, and kidney cancer.

Disclosures

BK Medical (Consultant); STIMIT (Clinical Advisory Board)

Recent Contributions to PracticeUpdate:

  1. Prognostic Value of the Systemic Immune–Inflammation Index and the Preoperative Systemic Immune–Inflammation Index in Patients With NMIBC Receiving BCG Therapy
  2. Experience of Treatment of Patients With High-Grade T1 Bladder Cancer Over 18 Years

Recently Updated